Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

The IXP Lifesciences Catalyst Fund has a greenshoe option of Rs 100 crore with an investment horizon of 3-5 years targeting ...

Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.

As we approach another year of groundbreaking research in cancer care and significant treatment innovations, various companies are taking the ...

As of today, the Indian Stock Market is giving an Earning Yield of 5% (~PE of 20). At the same time, US 30 year G-Sec Yield ...

The Biden-era law is now in the hands of a new administration, and drugmakers are scanning the horizon for hints of a massive ...

Novartis is paying $925 million upfront to acquire Anthos Therapeutics, whose launch the pharma backed in February 2019.

New evidence shows that bird flu, or avian influenza, is mutating beyond chickens and cows. A Nevada dairy worker tested ...

On Tuesday, Rosanna was joined by actresses Melissa Gilbert and Sheryl Underwood on Good Day New York. These doctors do NOT ...

Discover why PLUG is a Strong Buy with its 300% revenue growth, leadership in a booming market, and potential for 18.36% ...

Weak lending presents potential for future economic growth if interest rates are lowered. Read why I am more bearish about ...

Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a ...